文献
J-GLOBAL ID:201802265854885377
整理番号:18A1359088
JNK活性化を介したMCL-1のRASF6仲介阻害は腎細胞癌におけるソラフェニブの抗腫瘍効果を改善する【JST・京大機械翻訳】
RASSF6-mediated inhibition of Mcl-1 through JNK activation improves the anti-tumor effects of sorafenib in renal cell carcinoma
著者 (8件):
Liang Ying-Ying
(Department of Radiation Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China)
,
Deng Xu-Bin
(Department of Internal Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China)
,
Zeng Li-Si
(Department of Abdominal Surgery (Section 2), Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China)
,
Lin Xian-Tao
(Department of Radiation Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China)
,
Shao Xun-Fan
(Department of Radiation Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China)
,
Wang Bin
(Department of Urology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China)
,
Mo Zhi-Wen
(Department of Radiation Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China)
,
Yuan Ya-Wei
(Department of Radiation Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China)
資料名:
Cancer Letters
(Cancer Letters)
巻:
432
ページ:
75-83
発行年:
2018年
JST資料番号:
E0606B
ISSN:
0304-3835
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)